ACADIA Pharmaceuticals Inc Capital Reinvestment Ratio
ACADIA Pharmaceuticals Inc capital reinvestment ratio. ACADIA Pharmaceuticals Inc (ACAD) has a Capital Reinvestment Ratio of 0.08x as of June 2026, meaning it reinvests 0% of its operating cash flow ($134.76 Million) in capital expenditures ($10.30 Million). Check ACADIA Pharmaceuticals Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of ACADIA Pharmaceuticals Inc (2023–2025)
Capital reinvestment ratio of ACADIA Pharmaceuticals Inc from 2023 to 2025. This chart tracks ACADIA Pharmaceuticals Inc's Capital Reinvestment Ratio across 3 annual periods. Also explore ACADIA Pharmaceuticals Inc net asset momentum to track the company's year-over-year net asset growth rate.
ACADIA Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2023–2025)
ACADIA Pharmaceuticals Inc capital reinvestment ratio by year from 2023 to 2025. For the full cash flow conversion analysis, see ACAD operating cash flow.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | $109.84 Million | $4.69 Million | ▲ +1187.7% |
| 2024 | 0.00x | $157.72 Million | $523.00K | ▼ -99.9% |
| 2023 | 2.40x | $16.70 Million | $40.05 Million | — |